Social Media and Professional Development for Oncology Professionals.


Journal

JCO oncology practice
ISSN: 2688-1535
Titre abrégé: JCO Oncol Pract
Pays: United States
ID NLM: 101758685

Informations de publication

Date de publication:
08 2022
Historique:
pubmed: 22 3 2022
medline: 13 8 2022
entrez: 21 3 2022
Statut: ppublish

Résumé

The use of social media continues to increase in health care and academia. Health care practice, particularly the oncologic field, is constantly changing because of new knowledge, evidence-based research, clinical trials, and government policies. Therefore, oncology trainees and professionals continue to strive to stay up-to-date with practice guidelines, research, and skills. Although social media as an educational and professional development tool is no longer completely new to medicine and has been embraced, it is still under-researched in terms of various outcomes. Social media plays several key roles in professional development and academic advancement. We reviewed the literature to evaluate how social media can be used for professional development and academic promotion of oncology professionals.

Identifiants

pubmed: 35312343
doi: 10.1200/OP.21.00761
pmc: PMC9377722
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

566-571

Subventions

Organisme : NCI NIH HHS
ID : R13 CA239613
Pays : United States

Références

J Med Internet Res. 2011 Dec 19;13(4):e123
pubmed: 22173204
ESMO Open. 2021 Apr;6(2):100104
pubmed: 33838532
JAMA. 2017 Oct 3;318(13):1221-1222
pubmed: 28880990
J Med Internet Res. 2020 Sep 1;22(9):e19746
pubmed: 32870160
Future Oncol. 2017 Jun;13(15):1281-1285
pubmed: 28589770
AJOB Empir Bioeth. 2020 Apr-Jun;11(2):77-82
pubmed: 31663810
Future Oncol. 2016 Jul;12(13):1549-52
pubmed: 27025657
Semin Hematol. 2017 Oct;54(4):198-204
pubmed: 29153081
Acad Med. 2022 Jan 1;97(1):105-110
pubmed: 34348378
J Patient Cent Res Rev. 2018 Apr 26;5(2):149-157
pubmed: 31413999
J Med Internet Res. 2015 Apr 23;17(4):e103
pubmed: 25908092
J Med Internet Res. 2021 May 31;23(5):e28859
pubmed: 34057413
Clin Med (Lond). 2021 Sep;21(5):e475-e479
pubmed: 34507932
Neurooncol Pract. 2020 Jul 29;7(6):676-684
pubmed: 33304602
J Med Internet Res. 2020 Apr 17;22(4):e12288
pubmed: 32301733
Eur J Surg Oncol. 2020 Jul;46(7):1377-1383
pubmed: 32127248
Res Pract Thromb Haemost. 2021 Mar 08;5(2):253-260
pubmed: 33733023
J Oncol Pract. 2017 Jul;13(7):e623-e631
pubmed: 28514195
Ann Intern Med. 2013 Apr 16;158(8):620-7
pubmed: 23579867
JAMA Intern Med. 2017 Mar 1;177(3):425-427
pubmed: 28114456
Am J Kidney Dis. 2017 Jun;69(6):827-836
pubmed: 28233653
J Oncol Pract. 2018 Dec;14(12):e758-e769
pubmed: 30537459
Nat Cancer. 2020;1(5):473-476
pubmed: 32346676
JCO Glob Oncol. 2021 Apr;7:455-463
pubmed: 33822643
Ann Surg Oncol. 2016 Oct;23(10):3418-22
pubmed: 27387677

Auteurs

Anusha Chidharla (A)

Department of Medical Oncology, Kansas University Medical Center, Kansas, KS.

Audun Utengen (A)

Symplur, Real Chemistry, San Francisco, CA.

Deanna J Attai (DJ)

Department of Surgery, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA.

Emily K Drake (EK)

Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada.

G J van Londen (GJ)

Department of Medicine, School of Medicine at the University of Pittsburgh, Pittsburgh, PA.

Ishwaria M Subbiah (IM)

Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.

Elizabeth Henry (E)

Division of Hematology/Oncology, Department of Medicine, Loyola University Stritch School of Medicine, Maywood, IL.

Martina Murphy (M)

Division of Hematology and Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL.

Maura M Barry (MM)

Division of Hematology and Oncology, The University of Vermont Larner College of Medicine, Burlington, VT.

Rami Manochakian (R)

Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.

Scott Moerdler (S)

Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.

Stacy Loeb (S)

Department of Urology and Population Health, New York University and Manhattan Veterans Affairs, New York, NY.

Stephanie L Graff (SL)

Lifespan Cancer Institute at Brown University, Providence, RI.

Yan Leyfman (Y)

Department of Hematology-Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.

Michael A Thompson (MA)

Aurora Cancer Care, Advocate Aurora Health, Milwaukee, WI.

Merry J Markham (MJ)

Division of Hematology and Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH